Dopaminergic influences on the P300 abnormality in Parkinson's disease

Journal of the Neurological Sciences

Volumn 158, Issue 1, 1998, Pages 83-87

  Sohn, Young H ^a   Kim, Gyung W ^a   Huh, Kyoon ^b   Kim, Jin Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

Cognitive function; Dementia; Dopamine; Event related potential; Levodopa; Parkinson's disease

Indexed keywords

DOPAMINE RECEPTOR; LEVODOPA; PROTEIN P300; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; DOPAMINERGIC SYSTEM; EVENT RELATED POTENTIAL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LATENT PERIOD; MALE; MOTOR ACTIVITY; NERVE CELL EXCITABILITY; PARKINSON DISEASE; PRIORITY JOURNAL;

ACOUSTIC STIMULATION; AGED; ANTIPARKINSON AGENTS; CHOLINERGIC ANTAGONISTS; COGNITION DISORDERS; DOPAMINE; DOPAMINE AGONISTS; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EVENT-RELATED POTENTIALS, P300; FEMALE; HUMANS; LEVODOPA; LONGITUDINAL STUDIES; MALE; MENTAL PROCESSES; MIDDLE AGED; PARKINSON DISEASE; REACTION TIME; SEVERITY OF ILLNESS INDEX;

EID: 0032508054     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(98)00102-6     Document Type: Article

References (35)

1. Agid Y, Javoy-Agid F, Ruberg M. Biochemistry of neurotransmitters in Parkinson's disease. In: Marsden CD, Fahn S, editors. Movement disorders 2. London: Butterworths, 1987:166-230.
2. Antal A, Pfeiffer R, Bodis-Wollner I Simultaneously evoked primary and cognitive visual evoked potentials distinguish younger and older patients with Parkinson's disease. J Neural Transm. 103:1996;1053-1067.
3. Antal A, Keri S, Bodis-Wollner I Dopamine D2 receptor blockade alters the primary and cognitive components of visual evoked potentials in the monkey Macaca fascicularis. Neurosci Lett. 232:1997;179-181.
4. Aotsuka A, Weate SJ, Drake ME, Paulson GW Event-related potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 36:1996;215-220.
5. Beckstead RM An autoradiographic examination of cortico-cortical and subcortical projections of the medio-dorsal projection (prefrontal) cortex in the rat. J Comp Neurol. 184:1979;43-62.
6. Bowen FP, Kamienny RS, Burns MM, Yahr MD Parkinsonism: effects of levodopa treatment on concept formation. Neurology. 25:1975;701-704.
7. Bodis-Wollner I, Borod JC, Cicero B, Haywood CS, Raskin S, Mylin L, Sliwinski M, Falk A, Yahr MD Modality dependent changes in event-related potentials correlate with specific cognitive functions in nondemented patients with Parkinson's disease. J Neural Transm (P-D Sect). 9:1995;197-209.
8. Duncan-Johnson CC, Donchin E The P300 component of the event-related brain potential as an index of information processing. Biol Psychol. 14:1982;1-52.
9. Ebmeier KP A quantitative method for the assessment of overall effects from a number of similar electrophysiological studies: description and application to event-related potentials in Parkinson's disease. Electroencephalogr Clin Neurophysiol. 84:1992;440-446.
10. Glover A, Ghilardi MF, Bodis-Wollner I, Onofrj M Alterations in event-related potentials (ERPs) of MPTP-treated monkeys. Electroencephalogr Clin Neurophysiol. 71:1988;461-468.
11. Goodin DS, Aminoff MJ Electrophysiological differences between demented and nondemented patients with Parkinson's disease. Ann Neurol. 21:1987;90-94.
12. Goodin DS, Squires KC, Starr A Long latency components of the auditory evoked potential in dementia. Brain. 101:1978;635-648.
13. Gotham AM, Brown RG, Marsden CD 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa. Brain. 111:1988;299-321.
14. Halgren E, Squires NK, Wilson CL, Rohrbaugh JW, Babb TL, Crandall PH Endogenous potentials in the human hippocampal formation and amygdala by infrequent events. Science. 210:1980;803-805.
15. Hansch EC, Syndulko K, Cohen SN, Goldberg ZI, Potvin AR, Tourtellotte WW Cognition in Parkinson disease: an event-related potential perspective. Ann Neurol. 11:1982;599-607.
16. Kelley AE, Domesick VB, Nauta WJH The amygdalostriatal projection in the rat - an anatomical study by anterograde and retrograde tracing methods. Neuroscience. 7:1982;615-630.
17. Levin BE, Llabre MM, Reisman S, Weiner WJ, Sanchez-Ramos J, Singer C, Brown MC Visuospatial impairment in Parkinson's disease. Neurology. 41:1991;365-369.
18. Marciani MG, Calabresi P, Stanzione P, Bernardi G Dopaminergic and noradrenergic responses in hippocampal slices preparation: evidences for different receptors. Neuropharmacology. 23:1984;303-307.
19. Mohr E, Fabbrini G, Ruggieri S, Fedio P, Chase TN Cognitive concomitants of dopamine system stimulation in Parkinsonian patients. J Neurol Neurosurg Psychiatry. 50:1987;1192-1196.
20. O'Donnell BF, Squires NK, Martz MJ, Chen J-R, Phay AJ Evoked potential changes and neuropsychological performance in Parkinson's disease. Biol Psychol. 24:1987;23-37.
21. Oishi M, Mochizuki Y, Hara M, Du C-M, Takasu T Effects of intravenous L-dopa on P300 and regional cerebral blood flow in parkinsonism. Int J Neurosci. 85:1996;147-154.
22. Pang S, Borod JC, Hernandez A, Bodis-Wollner I, Raskin S, Mylin I, Coscia L, Yahr MD The auditory P300 correlates with specific cognitive deficits in Parkinson's disease. J Neural Transm (P-D Sect). 2:1990;249-264.
23. Polich J, Ehlers CL, Otis S, Mandell AJ, Bloom FE P300 latency reflects the degree of cognitive decline in dementing illness. Electroencephalogr Clin Neurophysiol. 63:1986;138-144.
24. Prasher D, Findley L Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: an electrophysiological investigation. J Neurol Neurosurg Psychiatry. 54:1991;603-609.
25. Pullman SL, Watts RL, Juncos JL, Chase TN, Sanes JN Dopaminergic effects of single and choice reaction time performance in Parkinson's disease. Neurology. 38:1988;249-254.
26. Reinsel RA, Veselis RA, Feshchenko VA, Di Resta GR, Mawlawi O, Beattie B, Silbersweig D, Stern E, Blasberg R, Macapinlac H, Finn R, Goldsmith S, Larson S Target detection and the prefrontal cortex. A PET scan study of the P300 event-related potential. Ann NY Acad Sci. 769:1995;393-397.
27. Rogers D Bradyphrenia in parkinsonism: a historical review. Psychol Med. 16:1986;257-265.
28. Saint-Cyr JA, Taylor AE, Nicholson K. Behavior and the basal ganglia. In: Weiner WJ, Lang AE, editors. Advances in neurology. Raven Press, New York, 1995:1-28.
29. Sagliocco L, Bandini F, Pierantozzi M, Mari Z, Tzelepi A, Ko C, Gulzar J, Bodis-Wollner I Electrophysiological evidence for visuocognitive dysfunction in younger non-caucasian patients with Parkinson's disease. J Neural Transm. 104:1997;427-439.
30. Scatton B, Rouquier L, Javoy-Agid F, Agid Y Dopamine deficiency in the cerebral cortex in Parkinson's disease. Neurology. 32:1982;1039-1040.
31. Stanzione P, Calabresi P, Mercuri N, Bernardi G Dopamine modulates CA1 hippocampal neurons by elevating the threshold for spike generation: an in vitro study. Neuroscience. 13:1984;1105-1116.
32. Stanzione P, Fattapposta F, Giunti P, D'Alessio C, Tagliati M, Affricano C, Amabile G P300 variations in parkinsonian patients before and during dopaminergic monotherapy: a suggested dopamine component in P300. Electroencephalogr Clin Neurophysiol. 80:1991;446-453.
33. Starkstein S, Esteguy M, Berthier ML, Garcia H, Leiguarda R Evoked potentials, reaction time and cognitive performance in on and off phases of Parkinson's disease. J Neurol Neurosurg Psychiatry. 52:1989;338-340.
34. Velasco M, Velasco F, Velasco AL, Almanza X, Olvera A Subcortical correlates of the P300 potential complex in man to auditory stimuli. Electroencephalogr Clin Neurophysiol. 64:1986;199-210.
35. Wilson RS, Kaszniak AW, Klawans HL, Garron DC High speed memory scanning in parkinsonism. Cortex. 16:1980;67-72.